09/29/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 9/29/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the CentoSure SARS-CoV-2 RT-PCR Assay. The CentoSure SARS-CoV-2 RT-PCR Assay is authorized for use with dry oropharyngeal swab specimens from individuals without symptoms or other reasons to suspect COVID-19. (PDF)
No hay comentarios:
Publicar un comentario